Table 1 Characteristics of the study population (n = 20).

From: Volatile organic compounds in exhaled breath of newborns: a pilot study

 

GA

Postnatal age

Race

Birth weight

Current weight

Feeding

Respiratory support

FiO2

Patient 1

24 + 2

37

White

541

1388

Formula

CPAP

21

Patient 2

23 + 1

29

Black

500

970

Formula

CPAP

21

Patient 3

28 + 2

13

Other

1255

1278

Breast milk

CPAP

21

Patient 4

28 + 1

14

Other

1190

1260

Breast milk

CPAP

23

Patient 5

26 + 4

20

Black

1162

1180

Breast milk

NIV-NAVA

30

Patient 6

27 + 2

9

White

1152

1030

Breast milk

CPAP

35

Patient 7

28 + 2

22

White

1255

1458

Breast milk

HFNC

21

Patient 8

26 + 3

10

Black

1160

1121

Breast milk

CPAP

21

Patient 9

23 + 1

54

White

550

1700

Formula

NIMV

30

Patient 10

23 + 1

51

White

581

1380

Formula

HFNC

35

Patient 11

41 + 1

6

White

3130

3194

Breast milk

NC

21

Patient 12

39 + 5

7

Black

3180

3200

Breast milk

None

21

Patient 13

40 + 2

6

White

3090

3070

Breast milk

None

21

Patient 14

37 + 1

28

White

2820

3213

Formula

None

21

Patient 15

38 + 0

20

Black

2900

3150

Formula

None

21

Patient 16

37 + 3

22

White

2870

3210

Formula

None

21

Patient 17

39 + 0

7

Hispanic

2650

2700

Formula

NC

21

Patient 18

38 + 5

8

Hispanic

2720

2810

Formula

HFNC

24

Patient 19

39 + 1

6

Asian

2690

2730

Formula

None

21

Patient 20

39 + 0

8

Hispanic

2660

2730

Formula

None

21

  1. GA gestational age in weeks + days, Postnatal age in days, Weight in grams. FiO2 fraction of inspired oxygen, in percentage.
  2. CPAP continuous positive airway pressure, NC nasal cannula, HFNC high flow nasal canula, NIMV noninvasive nasal intermittent ventilation, NIV-NAVA non-invasive-neurally-adjusted ventilatory assist.